Adverse Event Reporting in Clinical Trials: A Comprehensive Guide
Adverse Event Reporting involves documenting any untoward medical occurrence in a clinical trial participant, regardless of causal relationship to the investigational product. Regulatory bodies like the FDA, EMA, and CDSCO mandate strict adherence to adverse event documentation and submission procedures to maintain the integrity of clinical studies and ensure participant safety.
Click to read the full article.